Asia-Pacific qPCR Market Research Report Data Analysis by Product & Services, by Application, by Disease Type, by End User Forecast to 2032

Description

List of Tables

Asia-Pacific qPCR Market Research Report Data Analysis by Product & Services (Product & Services), by Application (Clinical, RUO, and Forensic), by Disease Type (Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others), by End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Forecast to 2032

Market Overview

The Asia-Pacific qPCR Market is expected to grow significantly at a CAGR of 8.23% over the review period. Quantitative polymerase chain reaction (qPCR) is a molecular biology technique for amplifying and quantifying DNA molecules. It is an extremely sensitive approach for detecting and quantifying the presence of a specific DNA sequence in a sample. qPCR uses fluorescent dyes or probes to bind to the amplified DNA during the process. The fluorescence released during amplification is monitored in real time, allowing the original amount of DNA in the sample to be quantified. This technique is widely utilized for a variety of purposes, including gene expression analysis, pathogen identification, and genetic testing.

The rising prevalence of various diseases in Asia-Pacific, together with technological developments in qPCR products, is driving the growth of the qPCR market. Furthermore, the high cost of qPCR solutions limits the market's potential. However, increased financing for genetic research will create future market growth prospects.

Market Segmentation

The Asia-Pacific qPCR Market is split into Product and Services.

The Asia-Pacific qPCR Market is divided into three applications: clinical, RUO, and forensics.

The market has been classified by illness type: newborn diseases, respiratory, STI, oncology, gastroenteritis, tropical diseases, herpes virus infections, and others.

The Asia-Pacific qPCR Market has been classified into end users, hospitals and clinics, diagnostic centers and laboratories, pharmaceutical and biotechnology companies, forensic laboratories, and others.

The market was worth USD 8,269.28 million in 2023 and is expected to increase at a CAGR of 8.23% over the forecast period. Asia-Pacific is further divided into China, India, Japan, South Korea, Australia, Taiwan, Hong Kong, and the Rest of Asia-Pacific.

Major players include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers AG, QIAGEN N.V., Eurofins Scientific, and Danaher Corporation.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING INCIDENCES OF VARIOUS DISEASES ACROSS ASIA-PACIFIC
- 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN QPCR PRODUCTS
4.3 RESTRAINTS
- 4.3.1 HIGH COST ASSOCIATED WITH QPCR SOLUTION
4.4 OPPORTUNITY
- 4.4.1 INCREASING FUNDING FOR GENOMIC RESEARCH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ASIA-PACIFIC QPCR MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON DEMAND AND SUPPLY

6 ASIA-PACIFIC QPCR MARKET, BY PRODUCT & SERVICES

6.1 OVERVIEW
6.2 PRODUCT
6.3 SERVICES

7 ASIA-PACIFIC QPCR MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 CLINICAL
7.3 RUO
7.4 FORENSIC

8 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE

8.1 NEW BORN DISEASES
8.2 RESPIRATORY
8.3 STI
8.4 ONCOLOGY
8.5 GASTROENTERITIS
8.6 TROPICAL DISEASES
8.7 HERPES VIRUS INFECTIONS
8.8 OTHERS

9 ASIA-PACIFIC QPCR MARKET, BY END USER

9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS & LABORATORIES
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4 FORENSIC LABORATORIES
9.5 OTHERS

10 ASIA-PACIFIC QPCR MARKET, BY COUNTRY

10.1 OVERVIEW
- 10.1.1 CHINA
- 10.1.2 INDIA
- 10.1.3 JAPAN
- 10.1.4 SOUTH KOREA
- 10.1.5 AUSTRALIA
- 10.1.6 TAIWAN
- 10.1.7 HONG KONG
- 10.1.8 REST OF ASIA-PACIFIC

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS FOR PRODUCTS, 2023
11.3 MARKET SHARE ANALYSIS FOR SERVICE, 2023
11.4 COMPETITOR DASHBOARD
11.5 PUBLIC PLAYERS STOCK SUMMARY
11.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

12 COMPETITIVE LANDSCAPE

12.1 THERMO FISHER SCIENTIFIC, INC.
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
12.2 SIEMENS HEALTHINEERS AG
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGIES
12.3 ABBOTT
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 SWOT ANALYSIS
- 12.3.6 KEY STRATEGIES
12.4 F. HOFFMANN-LA ROCHE LTD
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 SWOT ANALYSIS
- 12.4.6 KEY STRATEGIES
12.5 BGI GENOMICS
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 SERVICES OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 SWOT ANALYSIS
- 12.5.6 KEY STRATEGIES
12.6 EUROFINS SCIENTIFIC
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 SERVICES OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 SWOT ANALYSIS
- 12.6.6 KEY STRATEGIES
12.7 QIAGEN N.V.
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 SERVICES OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 SWOT ANALYSIS
- 12.7.6 KEY STRATEGIES
12.8 DANAHER CORPORATION
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGIES
12.9 GENEWIZ, INC.
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 SERVICES OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 SWOT ANALYSIS
- 12.9.6 KEY STRATEGIES
12.10 1ST BASE
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 SERVICES OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 SWOT ANALYSIS
- 12.10.6 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 ASIA-PACIFIC QPCR MARKET, BY PRODUCT & SERVICES, 2019-2032 (USD MILLION)
TABLE 3 ASIA-PACIFIC QPCR MARKET, FOR PRODUCTS BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 4 ASIA-PACIFIC QPCR MARKET, FOR PRODUCT, BY TYPE 2019-2032 (USD MILLION)
TABLE 5 ASIA-PACIFIC QPCR MARKET, FOR SERVICES BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 6 ASIA-PACIFIC QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 7 ASIA-PACIFIC QPCR MARKET, FOR CLINICAL, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 8 ASIA-PACIFIC QPCR MARKET, FOR RUO BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 9 ASIA-PACIFIC QPCR MARKET, FOR FORENSIC BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 10 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 11 ASIA-PACIFIC QPCR MARKET, FOR NEW BORN DISEASES BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 12 ASIA-PACIFIC QPCR MARKET, FOR NEW BORN DISEASES BY TYPE, 2019-2032 (USD MILLION)
TABLE 13 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 14 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 15 ASIA-PACIFIC QPCR MARKET, FOR STI BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 16 ASIA-PACIFIC QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 17 ASIA-PACIFIC QPCR MARKET, FOR ONCOLOGY, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 18 ASIA-PACIFIC QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 19 ASIA-PACIFIC QPCR MARKET, FOR GASTROENTERITIS BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 20 ASIA-PACIFIC QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 21 ASIA-PACIFIC QPCR MARKET, FOR TROPICAL DISEASES BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 22 ASIA-PACIFIC QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 23 ASIA-PACIFIC QPCR MARKET, FOR HERPES VIRUS INFECTIONS BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 24 ASIA-PACIFIC QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 25 ASIA-PACIFIC QPCR MARKET, FOR OTHERS BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 26 ASIA-PACIFIC QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 27 ASIA-PACIFIC QPCR MARKET, FOR HOSPITALS & CLINICS BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 28 ASIA-PACIFIC QPCR MARKET, FOR DIAGNOSTIC CENTERS & LABORATORIES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 29 ASIA-PACIFIC QPCR MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 30 ASIA-PACIFIC QPCR MARKET, FOR FORENSIC LABORATORIES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 31 ASIA-PACIFIC QPCR MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 32 ASIA-PACIFIC: QPCR MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 33 ASIA-PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 34 ASIA-PACIFIC: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 35 ASIA-PACIFIC: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 36 ASIA-PACIFIC: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 37 ASIA-PACIFIC: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 38 ASIA-PACIFIC: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 39 ASIA-PACIFIC: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 40 ASIA-PACIFIC: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 41 ASIA-PACIFIC: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 42 ASIA-PACIFIC: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 43 ASIA-PACIFIC: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 44 ASIA-PACIFIC: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 45 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 46 CHINA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 47 CHINA: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 48 CHINA: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 49 CHINA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 50 CHINA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 51 CHINA: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 52 CHINA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 53 CHINA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 54 CHINA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 55 CHINA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 56 CHINA: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 57 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 58 INDIA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 59 INDIA: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 60 INDIA: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 61 INDIA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 62 INDIA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 63 INDIA: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 64 INDIA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 65 INDIA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 66 INDIA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 67 INDIA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 68 INDIA: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 69 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 70 JAPAN: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 71 JAPAN: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 72 JAPAN: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 73 JAPAN: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 74 JAPAN: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 75 JAPAN: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 76 JAPAN: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 77 JAPAN: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 78 JAPAN: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 79 JAPAN: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 80 JAPAN: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 81 SOUTH KOREA: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 82 SOUTH KOREA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 83 SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 84 SOUTH KOREA: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 85 SOUTH KOREA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 86 SOUTH KOREA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 87 SOUTH KOREA: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 88 SOUTH KOREA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 89 SOUTH KOREA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 90 SOUTH KOREA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 91 SOUTH KOREA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 92 SOUTH KOREA: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 93 AUSTRALIA: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 94 AUSTRALIA: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 95 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 96 AUSTRALIA: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 97 AUSTRALIA: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 98 AUSTRALIA: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 99 AUSTRALIA: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 100 AUSTRALIA: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 101 AUSTRALIA: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 102 AUSTRALIA: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 103 AUSTRALIA: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 104 AUSTRALIA: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 105 TAIWAN: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 106 TAIWAN: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 107 TAIWAN: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 108 TAIWAN: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 109 TAIWAN: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 110 TAIWAN: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 111 TAIWAN: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 112 TAIWAN: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 113 TAIWAN: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 114 TAIWAN: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 115 TAIWAN: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 116 TAIWAN: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 117 HONG KONG: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 118 HONG KONG: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 119 HONG KONG: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 120 HONG KONG: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 121 HONG KONG: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 122 HONG KONG: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 123 HONG KONG: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 124 HONG KONG: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 125 HONG KONG: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 126 HONG KONG: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 127 HONG KONG: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 128 HONG KONG: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 129 REST OF ASIA-PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION)
TABLE 130 REST OF ASIA-PACIFIC: QPCR MARKET, FOR PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 131 REST OF ASIA-PACIFIC: QPCR MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 132 REST OF ASIA-PACIFIC: QPCR MARKET, BY DISEASE TYPE, 2019-2032 (USD MILLION)
TABLE 133 REST OF ASIA-PACIFIC: QPCR MARKET, FOR NEW BORN, BY TYPE, 2019-2032 (USD MILLION)
TABLE 134 REST OF ASIA-PACIFIC: QPCR MARKET, FOR RESPIRATORY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 135 REST OF ASIA-PACIFIC: QPCR MARKET, FOR STI, BY TYPE, 2019-2032 (USD MILLION)
TABLE 136 REST OF ASIA-PACIFIC: QPCR MARKET, FOR ONCOLOGY, BY TYPE, 2019-2032 (USD MILLION)
TABLE 137 REST OF ASIA-PACIFIC: QPCR MARKET, FOR GASTROENTERITIS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 138 REST OF ASIA-PACIFIC: QPCR MARKET, FOR TROPICAL DISEASES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 139 REST OF ASIA-PACIFIC: QPCR MARKET, FOR HERPES VIRUS INFECTIONS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 140 REST OF ASIA-PACIFIC: QPCR MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 141 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 142 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 143 ABBOTT: PRODUCT OFFERED
TABLE 144 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 145 BGI GENOMICS: SERVICES OFFERED
TABLE 146 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW
TABLE 147 EUROFINS SCIENTIFIC: SERVICES OFFERED
TABLE 148 QIAGEN N.V.: SERVICES OFFERED
TABLE 149 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 150 GENEWIZ, INC.: SERVICES OFFERED
TABLE 151 1ST BASE: SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC QPCR MARKET: STRUCTURE
FIGURE 2 ASIA-PACIFIC QPCR MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE ASIA-PACIFIC QPCR MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: ASIA-PACIFIC QPCR MARKET
FIGURE 7 ASIA-PACIFIC QPCR MARKET, PRODUCT & SERVICES SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 8 ASIA-PACIFIC QPCR MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 9 ASIA-PACIFIC QPCR MARKET SHARE (%), BY PRODUCT & SERVICES, 2023
FIGURE 10 ASIA-PACIFIC QPCR MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 11 ASIA-PACIFIC QPCR MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 12 ASIA-PACIFIC QPCR MARKET SHARE (%), BY TYPE, 2023
FIGURE 13 ASIA-PACIFIC QPCR MARKET, DISEASE TYPE SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 14 ASIA-PACIFIC QPCR MARKET, BY DISEASE TYPE, 2023 & 2032 (USD MILLION)
FIGURE 15 ASIA-PACIFIC QPCR MARKET SHARE (%), BY DISEASE TYPE, 2023
FIGURE 16 ASIA-PACIFIC QPCR MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 17 ASIA-PACIFIC QPCR MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 18 ASIA-PACIFIC QPCR MARKET SHARE (%), BY END USER, 2023
FIGURE 19 ASIA-PACIFIC MARKET ANALYSIS: QPCR MARKET, 2019-2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC QPCR MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 21 ASIA-PACIFIC QPCR MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 22 ASIA-PACIFIC QPCR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 23 ASIA-PACIFIC QPCR MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 24 COMPETITOR DASHBOARD: ASIA-PACIFIC QPCR MARKET
FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 27 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 29 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 ABBOTT: SWOT ANALYSIS
FIGURE 31 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 33 BGI GENOMICS: SWOT ANALYSIS
FIGURE 34 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 35 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 QIAGEN N.V.: SWOT ANALYSIS
FIGURE 37 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 39 GENEWIZ, INC.: SWOT ANALYSIS
FIGURE 40 1ST BASE: SWOT ANALYSIS